Navigation Links
Ants Genetic Engineering Leads To Species Interdependency

Findings reported last week reveal how an evolutionary innovation involving the sharing of genes between two ant species has given rise to a deep-seated dependency between them for the survival of both species populations. The new work illustrates how genetic exchange through interbreeding between two species can give rise to a system of interdependence at a high level of biological organization - in this case, the production of worker ants for both species.

Millions of years before the first modern humans evolved, ants were practicing many of the social innovations we consider to be our own: division of labor, agriculture, and even slavery. Indeed, these traits have been taken to their extreme in many ant species, such as the case of slavemaker ants, which have become so specialized for raiding food from the colonies of other ants that they can no longer feed themselves or raise their younger siblings. Recent work on ants suggests that we may need to add genetic engineering to the list of innovations ants have evolved to employ. In two species of harvester ants, populations have been discovered in which queens mate with males of another species to produce genetically novel hybrid workers. In a new study, Dr. Sara Helms Cahan and colleagues demonstrate that both of the species involved have effectively given up the ability to produce pure-species workers in favor of the hybrids, thereby becoming completely dependent on one another for survival. Female ants are generally found in two forms: reproductive queens and sterile workers. The role, or caste, of an individual is determined for life at a certain stage in her development. In virtually all ant species, it is the environment in which a female is raised, rather than a genetic predisposition, that determines which caste she will adopt. However, in two harvester ant populations in southern New Mexico, queens and workers from the same colonies are genetically very different; in both species at the site, only t he queens are genetically derived from a pure species-specific lineage, whereas all the workers are hybrids that possess a combination of genes from the two species in a single individual. It is not currently known whether the ants benefit from having hybrids do the work, but, as is evident from the researchers' own attempts at selective breeding and genetic engineering, combining genomes is an easy way to produce novel characteristics that may be highly advantageous for growth, environmental tolerance, or disease resistance. Regardless of the specific advantages, however, it is clear that these ants have committed themselves to the hybrid workforce strategy. When the researchers prevented queens from mating with males of the other species, very few succeeded in making any workers at all, a handicap that would lead to certain population failure in the field. The new findings suggest that specialization involving reliance on interspecific hybrid workers has left these species unable to survive independently of one another. Sara Helms Cahan, Glennis E. Julian, Steven W. Rissing, Tanja Schwander, Joel D. Parker, and Laurent Keller: "Loss of Phenotypic Plasticity Generates Genotype-Caste Association in Harvester Ants" Published in Current Biology, Volume 14, Number 24, December 14, 2004, pages 2277?282.
'"/>

Source:Space Daily


Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Genetically modified natural killer immune cells attack, kill leukemia cells
3. Genetic Variation Visualization - From EMBL
4. Genetically modified rice in China benefits farmers health, study finds
5. Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells
6. Genetically Modified Natural Killer Immune Cells Attack, Kill Leukemia Cells
7. Genetic defects give the immune system the green light to attack the pancreas
8. Maine Researchers Find Exceptions to Old Rules of Genetic Inheritance
9. Genetic therapy reverses nervous system damage in animal model of inherited human disease
10. Infants with Rare Genetic Disease Saved By Cord Blood Stem Cells
11. Researchers Find New Technique To Identify Fetal Genetic Material From Amniotic Fluid

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: